Tag: LILLY DRN
Eli Lilly to release weight loss pill orforglipron trial data
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.Scott Olson | Getty ImagesPatie [...]
Zepbound copycats remain online despite FDA ban
This week was supposed to mark the end of compounding pharmacies making copycat versions of Eli Lilly's weight-loss drug Zepbound and its diabetes dru [...]
Amgen weight loss drug MariTide starts two phase three trials
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023.Mario Tama | Getty ImagesAmgen on Wednesday said [...]
Novo Nordisk offers discounted Wegovy through direct-to-consumer pharmacy
Novo Nordisk's Wegovy weight loss drug has seen a meteoric rise in popularity. Nurphoto | Getty ImagesNovo Nordisk on Wednesday said it will offer its [...]
Eli Lilly to invest $27 billion in new U.S. manufacturing
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.Scott Olson | Getty ImagesEli L [...]
Eli Lilly offers higher Zepbound weight loss drug doses on LillyDirect
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Brendan McDermid | ReutersEli Lilly on Tues [...]
FDA says Wegovy and Ozempic shortage resolved; Hims & Hers stock falls
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy.Hollie Adams | ReutersThe long-running U.S. shortage of Novo Nordisk's blockbu [...]
Eli Lilly to take big swings in Alzheimer’s, ALS and gene therapy
Heart disease. Hearing loss. Addiction. Chronic pain. Alzheimer's. ALS. These are some of the areas where Eli Lilly, flush with cash from its GLP-1 dr [...]
Eli Lilly Dan Skovronsky discusses weight loss drugs
Dan Skovronsky knows what makes a good obesity drug.As chief scientific officer at Eli Lilly, he's already done it once with the company's weekly shot [...]
Eli Lilly to release data on weight loss drug retatrutide in 2025
The Eli Lilly & Co. logo at the company's Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024. Ore Huiying | Bloomberg [...]
Eli Lilly (LLY) earnings Q4 2024
Eli Lilly on Thursday reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and diabetes treatme [...]
CEO Lars Fruergaard Jorgensen discusses Wegovy
It's been a rocky few months for Novo Nordisk.Prescription data from IQVIA suggests Novo's obesity drug Wegovy is losing ground to rival Zepbound from [...]
Food as medicine startups could benefit
Robert Kennedy Jr., U.S. President-elect Donald Trump's nominee to run the Department of Health and Human Services, arrives at the Hart Senate Office [...]
Novo Nordisk’s Ozempic wins FDA approval for chronic kidney disease
The Food and Drug Administration on Tuesday approved Novo Nordisk's Ozempic to treat chronic kidney disease in patients who also have Type 2 diabetes, [...]
Trump health care plan likely good for pharmaceutical companies
U.S. President Donald Trump speaks about prescription drug prices during an appearance in the Brady Press Briefing Room at the White House in Washingt [...]